Related Experiment Videos
[Chordomas in ENT (author's transl)]
Laryngologie, Rhinologie, Otologie
|February 1, 1980
Summary
Chordomas are rare tumors originating from embryonic remnants. This study highlights treatment challenges and poor survival rates in five observed cases, emphasizing the difficulty in optimal management.
Area of Science:
- Oncology
- Otorhinolaryngology (ENT)
- Embryology
Background:
- Chordomas arise from intraosseous remnants of the embryonal notochord.
- They most commonly occur in the clival, sacrococcygeal, and vertebral regions.
- In ENT, they present as pharyngeal tumors with characteristic lobulated patterns.
Observation:
- Five cases of chordoma were observed and treated at an ENT center between 1965 and 1977.
- Treatment modalities included surgery alone, combined radiosurgery, and neutron-ray radiotherapy.
- Tumor growth patterns and physical characteristics were noted.
Findings:
- A significant challenge exists in determining the optimal treatment strategy for chordomas.
- Survival rates were poor, with most patients dying within three years due to the tumor or treatment complications.
- One patient treated with neutron-ray radiotherapy did not survive three years.
Implications:
- The study underscores the aggressive nature of chordomas and the limitations of current therapeutic approaches.
- Further research is needed to improve treatment efficacy and patient outcomes for this rare tumor.
- Multidisciplinary approaches may be essential for managing chordoma patients.